Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > VA Providers

Dr. Mark T. Fleming, MD

Accepting New Patients

(No ratings)

Specializes in: Medical Oncology, Adult Oncology and Adult Hematology

University of Toledo College of Medicine (1999)

Professional interests include: cancer

3000 Coliseum Drive Suite 104
Hampton, VA 23666

(757) 873-9800

Dr. Mark T. Fleming, MD is a medical oncologist in Hampton, VA specializing in medical oncology, adult oncology and adult hematology. He graduated from University of Toledo College of Medicine in 1999 and has 27 years of experience. Dr. Mark T. Fleming, MD is affiliated with Bon Secours Mary Immaculate Hospital, Bon Secours, Bon Secours Mary Immaculate Hospital, Virginia Oncology Associates, Sentara Health and VIRGINIA ONCOLOGY ASSOCIATES.

Office Locations

Sentara Health

3000 Coliseum Drive Suite 104
Hampton, VA 23666

(757) 873-9800

open_in_new

Virginia Oncology Associates

6251 E Virginia Beach Boulevard
Norfolk, VA 23502

(757) 466-8683

open_in_new

In The News (see more mentions in the news)

“"The ability to determine the extent and location of recurrent prostate cancer to inform appropriate clinical management is key for physicians and their patients, as up to 40% of patients who...”—"Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer", Associated Press News, May 2022

“Shown, from left, are John Searing (resident of Lee's Friends Board of Directors), Dr. Mark Fleming (Medical Oncologist with Virginia Oncology Associates) and Carol Olsen (Executive Director of...”—"First graders at Diamond Springs Elementary School learn about computers", The Virginian-Pilot, March 2020

“A special thank you goes out to Dr. Mark Fleming and his staff at Virginia Oncology Associates for 6 years of compassionate caring and understanding.”—"Brent Lewis", The Virginian-Pilot, January 2018

Noteworthy Medicare Patient Procedures Performed by Dr. Mark T. Fleming, MD in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Volume:

antineoplastic hormone therapy

biological response modifier therapy

complete blood count

intravenous chemotherapy

By Affordability:

CA 19-9 test

hospital care

immunofixation electrophoresis

inpatient care

inpatient hospital care

lipase test

protein electrophoresis

serum protein electrophoresis

In 2023, among providers in related specialties within Virginia, Dr. Mark T. Fleming, MD performed more antineoplastic hormone therapy, biological response modifier (BRM) therapy, complete blood count (CBC), intravenous (IV) chemotherapy, intravenous (IV) infusion, lab tests, thyroid blood test, total PSA test, and urinalysis procedures for Medicare patients than 95% of them and he also had a list price for CA 19-9 test, hospital care, immunofixation electrophoresis (IFE), inpatient care, inpatient hospital care (for patient admitted to hospital), lipase test, protein electrophoresis, and serum protein electrophoresis (SPEP) that was lower than the list prices billed to Medicare by 95% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 10%

By Volume:

blood draw

phlebotomy for lab tests

By Affordability:

carcinoembryonic antigen test

folic acid tests

serum folate test

urinalysis

In 2023, among providers in related specialties within Virginia, Dr. Mark T. Fleming, MD performed more blood draw, and phlebotomy for lab tests procedures for Medicare patients than 90% of them and he also had a list price for carcinoembryonic antigen (CEA) test, folic acid tests, serum folate test, and urinalysis that was lower than the list prices billed to Medicare by 90% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 25%

By Affordability:

beta-2 microglobulin test

blood draw

blood draw for lab tests

lactate dehydrogenase test

metabolic panel

phlebotomy for lab tests

prostate-specific antigen test

quantitative Ig tests

In 2012, Dr. Mark T. Fleming, MD had a list price for beta-2 microglobulin (B2M) test, blood draw, blood draw for lab tests, cancer antigen tests, complete blood count (CBC), IgA test, IgD test, IgG test, IgM test, immunoglobulin tests, iron tests, lactate dehydrogenase (LDH) test, metabolic panel, phlebotomy for lab tests, prostate-specific antigen (PSA) test, quantitative Ig tests, total IgA test, total IgG test, total PSA test, venipuncture (phlebotomy), and vitamin B12 test that was lower than the list prices billed to Medicare by 75% of providers in related specialties within Virginia. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Mark T. Fleming, MD treated as a medical oncologist in Hampton, VA during 2012 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Mark T. Fleming, MD for Medicare patients.

biological response modifier (BRM) therapy	566
blood draw	1518
chemotherapy	566
doctor visit	2473
hormone therapy	134
hospital care	485
inpatient care	485
lab tests	7769
minimally invasive procedures	702
musculoskeletal imaging	22
preventive care	130
vaccines	51
X-rays	22

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Mark T. Fleming, MD treated as a medical oncologist in Hampton, VA during 2013 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Mark T. Fleming, MD for Medicare patients.

biological response modifier (BRM) therapy	729
blood draw	1520
chemotherapy	729
doctor visit	2369
hormone therapy	128
hospital care	539
inpatient care	539
lab tests	7347
minimally invasive procedures	774
musculoskeletal imaging	23
preventive care	116
vaccines	66
X-rays	23

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark T. Fleming, MD.

**Gender**
Male	591
Female	484

**Ethnicity**
Non-Hispanic White	596
Black	442
Hispanic	14
Asian	0
Other	11
Native American	0

**Age**
From 65 to 74	454
From 75 to 84	377
85 and over	109
Less than 65	135

Conditions of Medicare patients treated by Dr. Mark T. Fleming, MD in 2013

Hypertension	75
High Cholesterol	57
Stroke	5
Ischemic Heart Disease	34
Depression	19
Chronic Kidney Disease	40
Asthma	8
Osteoperosis	7
Atrial Fibrilation	11
Heart Failure	20
Chronic Obstructive Pulmonary Disease	22
Diabetes	37
Dementia	9
Cancer	59

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Mark T. Fleming, MD treated as a medical oncologist in Hampton, VA during 2014 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Mark T. Fleming, MD for Medicare patients.

biological response modifier (BRM) therapy	600
blood draw	1549
chemotherapy	600
doctor visit	2398
hormone therapy	181
hospital care	291
inpatient care	291
lab tests	6841
minimally invasive procedures	731
port flush	22
preventive care	93
thyroid function tests	25
vaccines	62

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark T. Fleming, MD.

**Gender**
Male	630
Female	427

**Ethnicity**
Non-Hispanic White	562
Black	459
Hispanic	0
Asian	0
Other	16
Native American	0

**Age**
From 65 to 74	434
From 75 to 84	400
85 and over	104
Less than 65	119

Conditions of Medicare patients treated by Dr. Mark T. Fleming, MD in 2014

Hypertension	75
High Cholesterol	58
Stroke	5
Ischemic Heart Disease	35
Depression	19
Chronic Kidney Disease	40
Asthma	8
Osteoperosis	6
Atrial Fibrilation	12
Heart Failure	19
Chronic Obstructive Pulmonary Disease	20
Diabetes	37
Dementia	10
Cancer	57

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Mark T. Fleming, MD treated as a medical oncologist in Hampton, VA during 2015 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Mark T. Fleming, MD for Medicare patients.

biological response modifier (BRM) therapy	739
blood draw	1683
chemotherapy	739
doctor visit	2587
hormone therapy	215
hospital care	372
inpatient care	372
lab tests	7697
minimally invasive procedures	881
musculoskeletal imaging	33
nuclear scan	16
port flush	21
preventive care	47
thyroid function tests	24
vaccines	26
X-rays	17

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark T. Fleming, MD.

**Gender**
Male	1378
Female	952

**Ethnicity**
Non-Hispanic White	1330
Black	912
Hispanic	26
Asian	0
Other	36
Native American	0

**Age**
From 65 to 74	1000
From 75 to 84	800
85 and over	280
Less than 65	250

Conditions of Medicare patients treated by Dr. Mark T. Fleming, MD in 2015

Hypertension	75
High Cholesterol	58
Stroke	5
Ischemic Heart Disease	37
Depression	19
Chronic Kidney Disease	44
Asthma	15
Osteoperosis	7
Atrial Fibrilation	13
Heart Failure	23
Chronic Obstructive Pulmonary Disease	20
Diabetes	39
Dementia	11
Cancer	56

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Mark T. Fleming, MD treated as a medical oncologist in Hampton, VA during 2016 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Mark T. Fleming, MD for Medicare patients.

abdominal imaging	15
biological response modifier (BRM) therapy	853
blood draw	1856
chemotherapy	853
doctor visit	2484
hormone therapy	235
hospital care	169
inpatient care	169
lab tests	8134
minimally invasive procedures	1043
musculoskeletal imaging	11
port flush	35
preventive care	17
thyroid function tests	18
ultrasound (sonogram)	29
vaccines	17
vascular procedures	14
X-rays	11

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark T. Fleming, MD.

**Gender**
Male	710
Female	424

**Ethnicity**
Non-Hispanic White	651
Black	426
Hispanic	17
Asian	18
Other	22
Native American	0

**Age**
From 65 to 74	508
From 75 to 84	386
85 and over	141
Less than 65	99

Conditions of Medicare patients treated by Dr. Mark T. Fleming, MD in 2016

Hypertension	75
High Cholesterol	61
Stroke	5
Ischemic Heart Disease	37
Depression	18
Chronic Kidney Disease	48
Asthma	25
Osteoperosis	8
Atrial Fibrilation	13
Heart Failure	22
Chronic Obstructive Pulmonary Disease	25
Diabetes	39
Dementia	12
Cancer	55

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Mark T. Fleming, MD treated as a medical oncologist in Hampton, VA during 2017 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Mark T. Fleming, MD for Medicare patients.

abdominal imaging	13
biological response modifier (BRM) therapy	908
blood draw	2047
chemotherapy	908
doctor visit	2494
hormone therapy	220
hospital care	237
inpatient care	237
lab tests	8758
minimally invasive procedures	1061
musculoskeletal imaging	15
port flush	31
preventive care	20
thyroid function tests	233
ultrasound (sonogram)	13
vaccines	20
X-rays	15

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark T. Fleming, MD.

**Gender**
Male	686
Female	425

**Ethnicity**
Non-Hispanic White	659
Black	409
Hispanic	11
Asian	11
Other	21
Native American	0

**Age**
From 65 to 74	509
From 75 to 84	385
85 and over	116
Less than 65	101

Conditions of Medicare patients treated by Dr. Mark T. Fleming, MD in 2017

Hypertension	75
High Cholesterol	51
Stroke	6
Ischemic Heart Disease	40
Depression	19
Chronic Kidney Disease	49
Asthma	8
Osteoperosis	7
Atrial Fibrilation	14
Heart Failure	23
Chronic Obstructive Pulmonary Disease	22
Diabetes	37
Dementia	10
Cancer	58

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Mark T. Fleming, MD treated as a medical oncologist in Hampton, VA during 2018 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Mark T. Fleming, MD for Medicare patients.

biological response modifier (BRM) therapy	979
blood draw	2499
chemotherapy	979
doctor visit	2755
hormone therapy	255
hospital care	224
inpatient care	224
lab tests	9508
minimally invasive procedures	1142
port flush	45
preventive care	24
thyroid function tests	318
vaccines	24

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark T. Fleming, MD.

**Gender**
Male	743
Female	482

**Ethnicity**
Non-Hispanic White	720
Black	443
Hispanic	15
Asian	17
Other	30
Native American	0

**Age**
From 65 to 74	559
From 75 to 84	436
85 and over	132
Less than 65	98

Conditions of Medicare patients treated by Dr. Mark T. Fleming, MD in 2018

Hypertension	75
High Cholesterol	62
Stroke	5
Ischemic Heart Disease	39
Depression	20
Chronic Kidney Disease	52
Asthma	9
Osteoperosis	7
Atrial Fibrilation	13
Heart Failure	24
Chronic Obstructive Pulmonary Disease	22
Diabetes	39
Dementia	11
Cancer	52

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Mark T. Fleming, MD treated as a medical oncologist in Hampton, VA during 2019 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Mark T. Fleming, MD for Medicare patients.

biological response modifier (BRM) therapy	943
blood draw	2602
chemotherapy	943
doctor visit	2594
hormone therapy	235
hospital care	214
inpatient care	214
lab tests	9412
minimally invasive procedures	1163
port flush	65
thyroid function tests	366

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark T. Fleming, MD.

**Gender**
Male	737
Female	440

**Ethnicity**
Non-Hispanic White	728
Black	402
Hispanic	0
Asian	0
Other	22
Native American	0

**Age**
From 65 to 74	528
From 75 to 84	439
85 and over	128
Less than 65	82

Conditions of Medicare patients treated by Dr. Mark T. Fleming, MD in 2019

Hypertension	75
High Cholesterol	63
Stroke	7
Ischemic Heart Disease	41
Depression	21
Chronic Kidney Disease	52
Asthma	7
Osteoperosis	8
Atrial Fibrilation	14
Heart Failure	25
Chronic Obstructive Pulmonary Disease	23
Diabetes	37
Dementia	12
Cancer	52

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Mark T. Fleming, MD treated as a medical oncologist in Hampton, VA during 2020 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Mark T. Fleming, MD for Medicare patients.

biological response modifier (BRM) therapy	1005
blood draw	2553
chemotherapy	1005
doctor visit	2484
hormone therapy	242
hospital care	85
inpatient care	85
lab tests	9924
minimally invasive procedures	1165
port flush	64
thyroid function tests	427

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark T. Fleming, MD.

**Gender**
Male	741
Female	388

**Ethnicity**
Non-Hispanic White	688
Black	397
Hispanic	0
Asian	0
Other	19
Native American	0

**Age**
From 65 to 74	513
From 75 to 84	408
85 and over	121
Less than 65	87

Conditions of Medicare patients treated by Dr. Mark T. Fleming, MD in 2020

Hypertension	75
High Cholesterol	64
Stroke	6
Ischemic Heart Disease	42
Depression	19
Chronic Kidney Disease	54
Asthma	7
Osteoperosis	8
Atrial Fibrilation	13
Heart Failure	25
Chronic Obstructive Pulmonary Disease	20
Diabetes	39
Dementia	11
Cancer	54

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Mark T. Fleming, MD treated as a medical oncologist in Hampton, VA during 2021 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Mark T. Fleming, MD for Medicare patients.

biological response modifier (BRM) therapy	1133
blood draw	2282
chemotherapy	1133
doctor visit	2647
hormone therapy	228
lab tests	11155
minimally invasive procedures	1352
port flush	57
thyroid function tests	626

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark T. Fleming, MD.

**Gender**
Male	717
Female	387

**Ethnicity**
Non-Hispanic White	695
Black	360
Hispanic	14
Asian	11
Other	24
Native American	0

**Age**
From 65 to 74	496
From 75 to 84	406
85 and over	126
Less than 65	76

Conditions of Medicare patients treated by Dr. Mark T. Fleming, MD in 2021

Hypertension	75
High Cholesterol	65
Stroke	5
Ischemic Heart Disease	38
Depression	20
Chronic Kidney Disease	52
Asthma	8
Osteoperosis	7
Atrial Fibrilation	11
Heart Failure	21
Chronic Obstructive Pulmonary Disease	17
Diabetes	38
Dementia	8
Cancer	57

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Mark T. Fleming, MD treated as a medical oncologist in Hampton, VA during 2022 were lab tests, blood draw, minimally invasive procedures and chemotherapy.

Volume of procedures performed by Dr. Mark T. Fleming, MD for Medicare patients.

biological response modifier (BRM) therapy	1035
blood draw	2223
chemotherapy	1035
doctor visit	2495
hormone therapy	252
hospital care	46
inpatient care	46
lab tests	11801
minimally invasive procedures	1185
port flush	62
thyroid function tests	662

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Mark T. Fleming, MD.

**Gender**
Male	786
Female	345

**Ethnicity**
Non-Hispanic White	710
Black	364
Hispanic	0
Asian	0
Other	27
Native American	0

**Age**
From 65 to 74	499
From 75 to 84	430
85 and over	144
Less than 65	58

Conditions of Medicare patients treated by Dr. Mark T. Fleming, MD in 2022

Hypertension	75
High Cholesterol	75
Stroke	9
Ischemic Heart Disease	33
Depression	19
Chronic Kidney Disease	34
Asthma	9
Osteoperosis	9
Atrial Fibrilation	19
Heart Failure	22
Chronic Obstructive Pulmonary Disease	22
Diabetes	38
Dementia	5
Cancer	71

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2022

Volume of procedures performed by Dr. Mark T. Fleming, MD for Medicare patients.

The highest averages for the top procedures that Dr. Mark T. Fleming, MD treated as a medical oncologist in Hampton, VA were lab tests, blood draw, minimally invasive procedures and chemotherapy.

abdominal imaging	14
biological response modifier (BRM) therapy	862
blood draw	2030
chemotherapy	862
doctor visit	2525
hormone therapy	211
hospital care	266
inpatient care	266
lab tests	8940
minimally invasive procedures	1018
musculoskeletal imaging	20
nuclear scan	16
preventive care	63
thyroid function tests	299
ultrasound (sonogram)	21
vaccines	38
vascular procedures	14
X-rays	17

Average Medicare Patient Data From 2012 - 2022

Information about Medicare patients treated by Dr. Mark T. Fleming, MD.

**Gender**
Male	701
Female	432

**Ethnicity**
Black / African American	419
Asian / Pacific Islander	5
Non-Hispanic White	667
Native American / Alaskan Native	0
Hispanic	8
Other	20

**Age**
75 to 84	406
85 and over	127
Less than 65	100
65 to 74	500

Average of Total of Conditions of Medicare patients treated by Dr. Mark T. Fleming, MD From 2012 - 2022

The highest averages of the most common conditions of Medicare patients that Dr. Mark T. Fleming, MD treated were hypertension, high cholesterol, cancer and chronic kidney disease.

Hypertension	68
High Cholesterol	55
Stroke	5
Ischemic Heart Disease	34
Depression	17
Chronic Kidney Disease	42
Asthma	9
Osteoporosis	6
Heart Failure	20
Chronic Obstructive Pulmonary Disease	19
Diabetes	34
Atrial Fibrillation	12
Dementia	9
Cancer	51

Education & Training

Dr. Mark T. Fleming, MD graduated from University of Toledo College of Medicine in 1999. He completed residency at Temple University Hospital, Episcopal Campus. He is certified by the Medical Oncology and has a state license in Virginia.

Medical School: University of Toledo College of Medicine (1999)

Residency: Temple University Hospital, Episcopal Campus (2002)

Board Certification: Medical Oncology

Licensed In: Virginia

Affiliations & Hospitals

Dr. Mark T. Fleming, MD is associated with these hospitals and organizations:

Bon Secours Mary Immaculate Hospital

Bon Secours

Bon Secours Mary Immaculate Hospital

Virginia Oncology Associates

Sentara Health

VIRGINIA ONCOLOGY ASSOCIATES

Ratings & Reviews

Dr. Mark T. Fleming, MD does not have any reviews yet, be the first to leave a review of Dr. Mark T. Fleming, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Mark T. Fleming, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Janssen Biotech, Inc.	$22,622 Erleada $22,092	DARZALEX $500	Balversa $29
Astellas Pharma US Inc	$20,298 XTANDI $20,298
Medivation Inc.	$12,058 XTANDI $12,058
Novartis Pharmaceuticals Corporation	$11,205 Lutathera $4,725	$6,480
Genentech USA, Inc.	$6,491 TECENTRIQ $6,491
Other	$24,937 JEVTANA $4,857	NonCovered Product $2,945	Non-Covered Product $2,465	Nubeqa $2,284	PROVENGE $1,782	Other $10,604

**Types of Payments**
Consulting Fee	$49,211
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$41,441
Travel and Lodging	$3,503
Food and Beverage	$3,131
Education	$323

Research Payments

Dr. Mark T. Fleming, MD has received 1498 research payments totaling $9,627,664.

Biography

Dr. Mark Fleming specializes in adult hematology, adult oncology, and medical oncology and practices in Hampton, VA and Norfolk, VA. He studied medicine at the University of Toledo College of Medicine. For his residency, Dr. Fleming trained at Temple University Hospital, Episcopal Campus. His areas of expertise include cancer. He is professionally affiliated with Bon Secours Mary Immaculate Hospital, Virginia Oncology Associates, and Sentara Health. Virginia Oncology Associates reports that Dr. Fleming is accepting new patients at his office in Hampton, VA.